The report provides a detailed analysis essential for establishing a sodium oxybate production plant. It encompasses all critical aspects necessary for sodium oxybate production, including the cost of sodium oxybate production, sodium oxybate plant cost, sodium oxybate production costs, and the overall sodium oxybate production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a sodium oxybate production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.
Sodium oxybate is a central nervous system depressant that is used to treat narcolepsy symptoms. It is used to manage cataplexy (sudden muscle weakness) and excessive daytime sleepiness in adults and children aged 7+. It improves sleep quality by mimicking the brain's natural GABA activity, taken as an oral solution in two nighttime doses. It is approved for alcohol withdrawal syndrome and dependence maintenance as well as fibromyalgia pain and sleep issues. It is also utilised for treating Parkinson's disease-related sleep disorders to improve nighttime rest and motor symptoms and essential tremor reduction. It is used for opioid withdrawal support as an adjunct therapy and in chronic fatigue syndrome for better sleep architecture.
The market for sodium oxybate is fuelled by rising narcolepsy cases, greater awareness of sleep disorders like cataplexy and excessive daytime sleepiness. Its expanded pediatric approvals and innovations in extended-release formulations contribute to its market growth. The increasing healthcare access in developing markets and ongoing R&D for new indications further support demand. The high costs because of controlled substance status and strict regulatory compliance for distribution via risk evaluation programs like REMS affect industrial sodium oxybate procurement. Other factors like limited generic competition post-patent expiry, supply chain instabilities from specialised production, and payer pressures favouring cost-effective alternatives impact its sourcing.
Raw Material for Sodium Oxybate Production
According to the sodium oxybate production plant project report, the key raw materials used in the production of sodium oxybate include gamma-butyrolactone and sodium hydroxide.
Production Process of Sodium Oxybate
The extensive sodium oxybate production cost report consists of the following major industrial production process:
- From gamma-butyrolactone and sodium hydroxide: The production of sodium oxybate involves an alkaline hydrolysis process. First, gamma-butyrolactone (GBL) is reacted with sodium hydroxide (NaOH) in a controlled hydrolysis step. This opens the lactone ring to form the corresponding sodium salt of gamma-hydroxybutyric acid. The resulting solution is concentrated, purified and dried to obtain pure sodium oxybate as the final product.
Sodium oxybate is a white to off-white crystalline powder that is highly hydrophilic and very soluble in aqueous solutions. It has a molecular formula of C4H7NaO3 and a molecular weight of 126.09 g/mol. It has a melting point of 145-147 degrees Celsius with 1 hydrogen bond donor, 3 acceptors, 3 rotatable bonds, and a topological polar surface area of 60.4 Ų. It has a heavy atom count of 8, a formal charge of 0, and a complexity of 64.3. It exists as a solid at room temperature, has a physiological charge of 0 in its sodium salt form and an acid dissociation pKa of approximately 4.7. All these physical and chemical properties make it useful as a central nervous system depressant.